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The presence of adventitial inflammation in correlation with atherosclerotic lesions has
been recognized for decades. In the last years, several studies have investigated the
relevance and impact of adventitial inflammation on atherogenesis. In the abdominal
aorta of elderly Apoe−/− mice, adventitial inflammatory structures were characterized
as organized ectopic lymphoid tissue, and therefore termed adventitial tertiary lymphoid
organs (ATLOs). These ATLOs possess similarities in development, structure and function
to secondary lymphoid organs. A crosstalk between intimal atherosclerotic lesions and
ATLOs has been suggested, and several studies could demonstrate a potential role for
medial vascular smooth muscle cells in this process. We here review the development,
phenotypic characteristics, and function of ATLOs in atherosclerosis. Furthermore, we
discuss the possible role of medial vascular smooth muscle cells and their interaction
between plaque and ATLOs.
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INTRODUCTION
Atherosclerosis is defined as a chronic inflammatory process of
the vascular wall (Nilsson and Hansson, 2008). Coronary artery
disease (CAD) and ischemic heart failure as the clinical conse-
quences of atherosclerosis are themajor cause of death worldwide,
which emphasizes the need for new therapeutic strategies (Go
et al., 2013). In addition to affecting the lipometabolism and low-
ering LDL levels, the manipulation of the chronic immunological
process has become of specific interest regarding its therapeutic
potential in atherosclerosis. However, despite intensive research
investigating the relationship between immunological processes
and the development of unstable atherosclerotic lesions, there are
still many open questions.
Numerous recent atherosclerosis studies have focused on the
intimal atherosclerotic lesion. However, the presence of adventi-
tial inflammation in correlation with atherosclerotic lesions has
been recognized for decades (Schwartz and Mitchell, 1962). Just
recently, these adventitial inflammatory structures have come
into focus, and Gräbner et al. (2009) first characterized some
of these cellular compounds as adventitial tertiary lymphoid
organs (ATLOs) in old Apoe−/− mice and established a stage
classification (Gräbner et al., 2009).
Tertiary lymphoid organs (TLOs) represent a novel form of
ectopic, highly organized immunological structures similar to
secondary lymphoid organs like lymph nodes. TLOs have been
found to the immunological activation of chronic inflamma-
tory diseases such as chronic infections, transplant rejection,
or autoimmune diseases. They develop by lymphoid neogene-
sis at the site of chronic inflammation with persistent antigen
stimulation (Neyt et al., 2012). Although the conditions of TLO
induction and their contribution to disease pathology are still not
fully understood, they seem to play an important role in local
antigen clearance, immune activation and thus affect the course
of disease.
When trying to understand the development and function of
TLOs during atherogenesis, the special architecture of the ves-
sel wall with three distinct layers has to be noted. Particularly
the vascular smooth muscle cells of the lamina media, separating
the lamina intima with the atherosclerotic lesion from the lam-
ina adventitia with the associated TLO, are of special interest as
they may serve as mediators between the intimal and adventitial
processes.
TERTIARY LYMPHOID ORGANS
Tertiary lymphoid organs develop by lymphoid neogenesis at sites
of chronic inflammation with persistent antigen stimulation. This
includes chronic infections, transplant rejection or autoimmune
diseases (Neyt et al., 2012). This process can take place within
or nearby the inflamed tissues (Moyron-Quiroz et al., 2004). In
particular, TLO formation could be confirmed in infections like
influenza (Moyron-Quiroz et al., 2004; Geurtsvankessel et al.,
2009) or Helicobacter pylori (Winter et al., 2010). Furthermore,
TLOs are associated with human chronic transplant rejection and
could be found during heart, lung, or kidney transplant rejec-
tion (Di Carlo et al., 2007; Thaunat et al., 2010; Sato et al., 2011).
Similarly, TLO formation could be confirmed inmultiple autoim-
mune diseases: thus, TLOs were found in joints and lung tissue
of rheumatoid arthritis patients (Rangel-Moreno et al., 2006),
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in the thyroid gland of patients with Hashimoto’s thyroiditis
(Armengol et al., 2001), in the pancreas of patients with diabetes
(Kendall et al., 2007) and in the central nervous system of patients
with multiple sclerosis (Franciotta et al., 2008). However, it still
remains unclear which specific immune conditions lead to TLO
induction.
TLOs are defined as an accumulation of lymphoid cells and
develop in response to chronic inflammation, either due to infec-
tion or autoimmunity (Sansonno et al., 2004; Aloisi and Pujol-
Borrell, 2006; Kendall et al., 2007; Carragher et al., 2008; Van De
Pavert and Mebius, 2010). A more precise definition of TLOs was
recently published by Neyt et al. (2012). In contrast to the chronic
cellular compound, TLOs can be defined by the following crite-
ria: TLOs (also known as ectopic lymphoid structures) represent
highly organized lymphoid cell formations similar to secondary
lymphoid organs like lymph nodes or the spleen. The struc-
tures of TLOs form a specific, well-organized network including
fibroblast reticular cells in the T cell area that warrant optimal
interactions of immune cells like antigen presentation, stimula-
tion, and cell differentiation (Fletcher et al., 2010). Similar to
lymph nodes, TLOs contain a mesenchymal network promot-
ing lymphocyte homing. Lymph vessels and high endothelial
venules (HEV; PNA+ or MECA79+), specialized for the recruit-
ment of lymphocytes from blood, facilitate lymphocyte migration
and are located in the T cell area. Furthermore, structured B
cell compartments containing germinal centers and activation-
induced cytidinedeaminase (Geurtsvankessel et al., 2009; Perros
et al., 2012) as well as T cell sections co-localized with antigen-
presenting cells, including follicular dendritic cells, can be found
(Fletcher et al., 2010). Figure 1 demonstrates a simplified illus-
tration of the structure of TLOs in the adventitia in correlation to
atherosclerotic lesions.
TLOs develop in a similar fashion as secondary lym-
phoid organs do. The development is orchestrated by various
chemokines. Accordingly, elevated levels of homeostatic cytokines
and chemokines like CXCL12, CXCL13, CCL20, CCL21, LTα and
LTβ were found at the site of chronic or autoimmune inflamma-
tion (Carragher et al., 2008). In the early phase, lymphoid tissue
inducer cells (LTi cells) expressing lymphotoxin α1β2 (LTα1β2)
interact with stromal lymphoid tissue organizer cells (LTo) carry-
ing the lymphotoxin β receptor (LTβR) on their surface thereby
inducing lymphoid organogenesis (Mebius, 2003; Muller and
Lipp, 2003). Investigation of TLO formation during chronic
inflammation or autoimmune processes revealed that several
immune cells can also function as LTi cells. McDonald et al.
showed that activated B cells expressing LTβ can induce TLO for-
mation in the murine mucosal immune system (McDonald et al.,
2005), while Marinkovic et al. identified mature CD3+CD4+ T
cells as potential triggers of TLO development (Marinkovic et al.,
2006). In experimental autoimmune encephalomyelitis – a mouse
model of multiple sclerosis – Peters et al. demonstrated that Th17
cells also contribute to the formation of TLOs (Peters et al., 2011).
Interestingly, IL-17—the distinctive cytokine of Th17 cells—also
seems to be important for the formation of inducible bronchus-
associated lymphoid tissue (iBALT) by inducing lymphotoxin
α-independent expression of CXCL13 in murine lungs (Rangel-
Moreno et al., 2011). Besides B and T cells, dendritic cells as the
most potent antigen presenting cell type are able to induce TLOs,
while the depletion of dendritic cells leads to their disappear-
ance (Geurtsvankessel et al., 2009; Halle et al., 2009; Muniz et al.,
2011). After activation, LTo cells express various chemokines
and cytokines leading to further recruitment of different lym-
phocytes. T cells are attracted by CCL19 and CCL21, whereas
CXCL13 triggers the recruitment of B cells. The development of
LYVE-1+ lymph vessels is promoted by the expression of lym-
phangiogenic growth factors like fibroblast growth factor (FGF),
vascular endothelial growth factor (VEGF), or hepatocyte growth
factor (HGF). This results in formation of a mesenchymal scaf-
fold for the recruitment of T and B cells, follicular dendritic cells,
and fibroblasts, leading to the development and progression of
lymphatic organogenesis.
The role of TLOs within the immune system is double-edged:
on the one hand, TLOs may help to eliminate pathogens dur-
ing infections like influenza (Moyron-Quiroz et al., 2004) and
thereby protect the organism against foreign antigens. On the
other hand, their development especially during autoimmunity
may lead to ongoing activation of predominantly autoimmune T
cells and subsequently disturb the balance between pro- and anti-
inflammatory factors leading to uncontrolled inflammation. This
disequilibrium may in turn lead to tissue destruction and organ
damage. The development and function of TLOs in general has
been excellently reviewed by Weih et al. (2012).
HISTORY OF ADVENTITIAL INFLAMMATION AND
ATHEROSCLEROSIS
In 1962, Schwartz et al. described for the first time a cellular
infiltration of the adventitia of human arteries associated with
atherosclerotic plaques (Schwartz and Mitchell, 1962). Although
this adventitial accumulation of cells has been recognized decades
ago, the main focus of atherosclerosis research has been on plaque
development within the intimal layer. Nonetheless, some studies
also addressed the role of the adventitial inflammatory process
in atherosclerosis. Thus, in 1981 Parums et al. suggested a cor-
relation between the degree of adventitial inflammation and the
severity of the atherosclerotic lesion (Parums and Mitchinson,
1981). In 1985, Kohchi et al. quantitatively analyzed adventitial
inflammation in coronary arteries of patients after fatal myocar-
dial infarction compared to patients who died due to non-cardiac
causes. This study pointed toward a possible relevance of adventi-
tial infiltration of immune cells with unstable CAD (Kohchi et al.,
1985). In the following years, several studies further character-
ized the cellular composition of these adventitial cell aggregations
(Wick et al., 1997; Houtkamp et al., 2001; Zhao et al., 2004; Moos
et al., 2005; Galkina et al., 2006; Watanabe et al., 2007). T and
B cells were shown to represent the main cell type within these
structures. In 2005, Moos et al. found an age-dependent increase
of adventitial T cell inflammation in Apoe−/− mice fed a nor-
mal chow diet (Moos et al., 2005). T and B cell clusters as well
as follicle-like structures were identified in abdominal aortas of
older Apoe−/− mice (Moos et al., 2005).
In 2009, Gräbner et al. were the first to show that these
adventitial cellular compounds can advance into tertiary lym-
phoid organs in the adventitia of abdominal aortas of Apoe−/−
mice (Gräbner et al., 2009). In this study, the authors precisely
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FIGURE 1 | Adventitial tertiary lymphoid organs (ATLOs) in
atherosclerosis. The cellularity and structure of ATLOs in the diseased vessel
wall is presented. ATLOs represent organized accumulation of different
lymphoid cells, developed in response to the chronic inflammatory process of
atherosclerosis. Stage III ATLOs show T and B cell areas. Germinal centers
with follicular dendritic cells surrounded by centrocytes and B cells are present.
Lymph vessels and high endothelial venules (HEV) facilitate the recruitment of
lymphocytes from the blood into ATLOs. Similar to lymph nodes, ATLOs
contain a mesenchymal network of conduits, connecting the lamina media
with HEVs in T cell areas. Small molecular weight molecules (such as
chemokines and cytokines) can be transported by these conduits. A cross-talk
between the plaque and the ATLO via the medial VSMCs is postulated.
analyzed the cellular composition and structure of ATLOs in
the adventitia of abdominal aortas of Apoe−/− mice and estab-
lished an ATLO stage classification. ATLO neogenesis was found
in the adventitia of abdominal aortas of some 32 weeks old
Apoe−/− mice on chow diet and occurred in >70% of mice
afflicted with atherosclerosis at 78 weeks (Gräbner et al., 2009).
They postulated that ATLOs appear in advanced late-stage
atherosclerosis. Interestingly, ATLOs always appeared in adven-
titial segments of the abdominal aorta affected by atheroscle-
rotic lesions and the lesion size correlated with the ATLO size
(Gräbner et al., 2009). Because of the co-localization of adven-
titial inflammatory structures and ATLOs with atherosclerotic
lesions, it was tempting to suggest an interaction between both
compartments in the vascular wall. The vascular smooth mus-
cle cells in the lamina media separating both compartments may
coordinate this crosstalk as we will discuss later in this review.
Table 1 gives an overview over the study’s investigating adventitial
inflammation in atherosclerosis.
DO ADVENTITIAL INFLAMMATORY PROCESSES REPRESENT
TLOs?
Human adventitial inflammation was firstly described in 1962
(Schwartz and Mitchell, 1962). The frequency of the inflamma-
tory compound next to atherosclerotic lesions varies between
publications, several studies found percentages between 70 and
100% (Houtkamp et al., 2001; Watanabe et al., 2007). Within
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Table 1 | Adventitial inflammation in relation to atherosclerosis.
References Organism Investigated vessel Main result
Schwartz and
Mitchell, 1962
Human Aorta, coronary artery, cervical and iliac
artery
Adventitial cellular infiltration associated to atherosclerotic
plaques
Parums and
Mitchinson, 1981
Human Coronary artery Correlation between adventitial inflammation and atherosclerotic
plaque
Kohchi et al., 1985 Human Coronary artery Relevance of adventitial inflammation to unstable CAD
Houtkamp et al.,
2001
human Aorta Similarity of adventitial lymphoid infiltrates and mucosa
associated lymphoid tissue MALT in advanced atherosclerosis
Moos et al., 2005 Apoe−/− mice Abdominal aorta Formation of inflammatory follicle-like structures in the
abdominal aorta of old Apoe−/− mice
Watanabe et al.,
2007
Human Coronary artery Formation of small lymph follicle-like structures in the adventitia
of coronary arteries
Gräbner et al., 2009 Apoe−/− mice Abdominal aorta Identification of ATLOs in the abdominal aorta of old Apoe−/−
mice
the adventitial inflammatory compounds, primarily T cells, but
also some B cells and dendritic cells are present. Later-stage
organized inflammatory compartments further contain lymph
follicles (Watanabe et al., 2007). But whether adventitial inflam-
matory compounds represent ATLOs remains unknown. In addi-
tion, it can be speculated whether these adventitial compounds
may transform to ATLOs, but in humans studies demonstrating
ATLOs are still lacking. Figure 2 illustrates the composition of
adventitial inflammation in atherosclerosis.
However, in mice Gräbner et al. convincingly showed that
adventitial inflammation at least partly represent ATLOs. ATLO
neogenesis occurred in mice older than 32 weeks on chow diet
in the abdominal aorta (Gräbner et al., 2009). But the detailed
definition of TLOs listed above is limited by the fact that cellular
inflammatory compartments may not fulfill all criteria, but still
function as TLO (Neyt et al., 2012). In addition, it is not known
whether all adventitial cellular compartments can be defined as
ATLOs. Thus, further studies are needed to investigate the possi-
ble role of adventitial inflammatory compounds in atherosclerosis
and the potential steps of the differentiation of adventitial inflam-
matory compounds toward ATLOs. In addition, it needs to be
elucidated whether the facts of TLO in the abdominal aorta are
transferable to other parts of the vascular tree.
MEDIAL VASCULAR SMOOTH MUSCLE CELLS: THE LINK
BETWEEN INTIMAL ATHEROSCLEROTIC LESIONS AND
ADVENTITIAL INFLAMMATION?
Based on the above mentioned data, there seems to be a com-
munication between the atherosclerotic lesion in the intima and
TLOs in the adventitia. Since both compartments of the arterial
wall are separated by vascular smooth muscle cells (VSCMs) in
the lamina media, it is likely that these VSMCs coordinate the
communication between both compartments. The direct traffic
of inflammatory cells through the smooth muscle layer of the
lamina media is limited (Dal Canto et al., 2001). As (Gräbner
et al., 2009) demonstrated, medial VSMCs surrounded by inti-
mal plaque and ATLOs were able to express the chemokines
CXCL13 and CCL21 through the LTßR-dependent signaling
pathway (Gräbner et al., 2009). CXCL13 and CCL21 are both
lymphorganogenic chemokines that are involved in the forma-
tion of secondary and tertiary lymphoid organs (Luster, 1998;
Luther et al., 2000; Chen et al., 2002; Cupedo and Mebius,
2005; Charo and Ransohoff, 2006). Gräbner et al. suggested that
activated VSCMs underlying atherosclerotic lesion develop prop-
erties of LTo cells and thereby induce ATLO neogenesis (Gräbner
et al., 2009). LTos are described as mesenchymal cells that control
embryonic lymph node development (Luther et al., 2002; Mebius,
2003; Carragher et al., 2008). In 2010, Lotzer et al. supported the
hypothesis that VSMCs may differentiate into LTo cells (Lotzer
et al., 2010). Simultaneous stimulation of mouse aortic smooth
muscle cells by TNF-α and LTßR signaling induced expression of
several homeostatic and lymphorganogenic chemokines, which
are thought to promote the recruitment of leukocytes to the
adventitia and thereby enable the formation of ATLOs (Lotzer
et al., 2010). Furthermore, Gräbner et al. could recognize lymph
node like conduits connecting medial VSMCs to ATLOs (Gräbner
et al., 2009); low molecular weight molecules can be transported
into ATLOs via these conduits (Gräbner et al., 2009). In lymph
nodes, similar conduits connect afferent lymph vessels and high
endothelial venules, coordinating the transport of antigens into
lymph nodes (Itano and Jenkins, 2003; Sixt et al., 2005). During
the development of secondary lymphoid organs, LTo cells are acti-
vated by lymphoid tissue inducer cells (Mebius, 2003). In 2014,
Guedj et al. demonstrated the capability of M1 macrophages
to act as LTi cells triggering the differentiation of VSMCs into
LTo cells (Guedj et al., 2014). They suggest that the interaction
between M1 macrophages and VSMCs may induce ATLO forma-
tion (Guedj et al., 2014). Taken together, all data published up to
date suggest that VSMCs may be involved in ATLO development
and interaction of atherosclerotic lesions with ATLOs. Figure 3
demonstrates the possible role of VSMCs in the lamina media
between ATLOs and atherosclerotic lesions in the development
of ATLOs.
CONCLUSIONS AND FUTURE DIRECTIONS
Atherosclerosis is a chronic (auto)immune process. To bet-
ter understand the underlying mechanisms, one should study
the entire vessel wall, including inflammatory compounds that
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FIGURE 2 | Adventitial inflammation in atherosclerosis. Intimal
atherosclerotic lesions are frequently accompanied by an inflammatory
process in the adjacent adventitia. This inflammatory process is
characterized by infiltration of T cells, B cells and dendritic cells in
the adventitia. In some cases T and B cell aggregations can be
seen. There is a correlation between the size of the intimal lesion
and the adventitial structures and a crosstalk between both
compartments is suggested.
develop in the adventitia. Over the past few years, we have gained
insight into the structure of these adventitial cellular compart-
ments. Recent studies convincingly show that murine adventitial
inflammation at least in part represents different stages of ATLOs.
In addition, there seems to be a crosstalk between the intimal
lesion and the adventitial cellular compartment through VSMCs.
On the basis of recent studies, it is tempting to postulate
a role for adventitial inflammation/ATLOs in the atherogene-
sis, however, the exact significance of these structures remains
enigmatic. A number of questions will have to be addressed
by future research: do the adventitial cellular compounds next
to atherosclerotic lesions in humans represent ATLOs? What
are the exact conditions under which adventitial inflammation
advances to ATLOs? Finally, are adventitial inflammatory com-
partments/ATLOs relevant for human atherogenesis and is their
presence associated with the development of unstable lesions?
Thus, further studies are needed to clarify the significance of
adventitial inflammation. This knowledge significantly advance
our understanding of chronic (auto)immune process of the entire
vessel wall.
One way, by which the role of ATLOs in human atherosclero-
sis may be elucidated, may be the application of novel diagnostic
imaging tools. For example, specific contrast agents in combi-
nation with dedicated magnetic resonance imaging (MRI) pulse
sequences nowadays enable the visualization of vessel wall thick-
ness and macrophage-rich inflammation within atherosclerotic
plaques (Kim et al., 2007; Korosoglou et al., 2008). These imaging
approaches may help to understand the underlying pathophysi-
ologic mechanisms and associations between intimal lesions and
adventitial inflammation in future studies.
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FIGURE 3 | The possible role of VSMCs in the formation of
Adventitial tertiary lymphoid organs (ATLOs). Pro-inflammatory
cytokines (such as TNF and LTα1β2) activate VSMCs by
TNFR-1 or LTßR signaling thereby inducing an LTo phenotype
in VSMCs. Activated VSMCs express lymphorganogenic
chemokines such as CCL19, CCL21, CXCL13, and CXCL16,
thereby orchestrating ATLO neogenesis and developement. I,
Intima; M, Media; A, Adventitia.
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